VKTX - Wall Street Estimates - Viking Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 28.87

0.698 %

$ 3.24 B

Market Cap

-28.58

P/E

Price Target Average

272.52%

Revenue Forecast Estimate

-0.00%

EBIT Estimate

18.92%

Net Income Estimate

22.61%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Viking Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for VKTX of $108 , with forecasts ranging from a low of $74 to a high of $138 .

VKTX Lowest Price Target Wall Street Target

74 USD 156.32%

VKTX Average Price Target Wall Street Target

108 USD 272.52%

VKTX Highest Price Target Wall Street Target

138 USD 378.00%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free